Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 15

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

233

HTML

2047

Figures (1-2)

165

Sum=2445

Apr 21, 2009 (publication date) through Aug 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Apr 21, 2009; 15(15): 1910-1913
Published online Apr 21, 2009. doi: 10.3748/wjg.15.1910

Full Size Figure Download Figure

Figure 1 CT scan image at pelvic showing a large low-density lesion arising from the rectum.

Citation: Hou YY, Zhou Y, Lu SH, Qi WD, Xu C, Hou J, Tan YS. Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor. World J Gastroenterol 2009; 15(15): 1910-1913
URL: https://www.wjgnet.com/1007-9327/full/v15/i15/1910.htm
DOI: https://dx.doi.org/10.3748/wjg.15.1910